IMMUNOTHERAPY OF RENAL-CELL CARCINOMA

Immunologic approaches to the therapy of metastatic renal cell carcino ma have provided moderate improvement in response rates for a disease that is extremely resistant to all forms of treatment. This article re views recent clinical efforts using immunotherapy for renal cell carci noma, including the adoptive transfer of cytotoxic killer cells and/or the use of biologic response modifiers, such as interferon and interl eukin-2.